Clinical study of Jingzhengfang in treating cervical spondylotic myelopathy

GAO Xiang,WU Tao,WANG Yong-jun,HU Zhi-jun,SHI Qi,HU Jun
DOI: https://doi.org/10.3969/j.issn.1008-8296.2007.01.019
2007-01-01
Abstract:Objective To study the effect of Jingzhengfang (prescription for convulsive disease) on patients with cervical spondylotic myelopathy. Methods 70 cases with cervical spondylotic myelopathy were divided into Jingzhengfang treatment group 35 cases and west medicine treatment group 35 cases randomly.The patients were assessed with scale for Cervical Spondylotic Myelopathy function and examined by effective rate before and after two therapies. Results The total response rate of the clinical treatment of cervical spondylotic myelopathy was 80.0%,and that of western medicine group was 57.14%.The effect of Jingzhengfang treatment group was improved remarkably than that of western medicine group(P<0.01). Conclusions Jingzhengfang has preferable clinical effect to Cervical Spondylotic Myelopathy.
What problem does this paper attempt to address?